On Monday, November 4th, 2024, NXTGEN Hightech, Invest-NL Deep Tech Fund, and Topsector Life Sciences & Health (Health~Holland International) are bringing together innovators, industry leaders, and investors for a Deep Dive into Lab-on-Chip, Organ-on-Chip, and biosensing technologies! Join us as we kick off with the Invest-NL Deep Tech Fund Report, which offers key insights into market opportunities, especially for #startups in the Netherlands. What to expect: 👉 Break-out sessions on market access, commercialization strategies, and funding opportunities 👉 A panel discussion on scaling Dutch biotech innovations for the European market 👉 Networking with top industry players and experts Register now and be part of this important conversation. https://lnkd.in/e7zzxxrP Feel free to bring a colleague and share the invite with your network! We look forward to seeing you there! #labonchip #organonchip #biosensing Ingrid Relou, Sabine Middendorp, Edwin Roovers
Biomed | NXTGEN Hightech
Productie medische apparatuur
Eindhoven, Noord-Brabant 239 volgers
A determined approach to transform knowledge into groundbreaking biomedical products.
Over ons
A strong value chain for the Netherlands Lab-on-chip, organ-on-chip, artificial organs, and cell production technology: the Netherlands is not lacking in knowledge. What is missing, however, is a determined approach to transform this knowledge into groundbreaking products. With the NXTGEN Hightech program, we are making the difference in this area. From knowledge to production The (academic) knowledge in the Netherlands is very high in the areas of Lab-on-Chip, Organ-on-Chip, Artificial Organs, and Cell Production Technology, but it is not (effectively) transformed into products. The main reason for this is the need for a multidisciplinary chain of suppliers of high-quality specialist components in both the technological and biological fields. A dynamic ecosystem We can achieve this by connecting pieces of existing technology together, for example, for the production of chips, cells, bioactive materials. The companies already exist, but because they come from different fields, they sometimes do not yet speak the same language, let alone have technologies that interconnect seamlessly. Therefore, we are creating an ecosystem, an environment, where we collaborate intensively and align technologies with each other. These are the projects that are currently active within the Biomedical domain: - One-stop-shop - Lab-on-a-chip - Organ-on-a-chip - Artificial Organs - Cel production technology
- Website
-
www.nxtgenhightech.nl
Externe link voor Biomed | NXTGEN Hightech
- Branche
- Productie medische apparatuur
- Bedrijfsgrootte
- 51 - 200 medewerkers
- Hoofdkantoor
- Eindhoven, Noord-Brabant
- Opgericht
- 2023
- Specialismen
- Lab-on-chip, Artificial Organs, Cell Production Technology, Medical Technology, Life Sciences, Biomedical, Healthcare, Biotechnology, Biosensing, organ-on-chip, microfluidics, nano coating en diagnostics
Updates
-
Exciting Collaboration to Accelerate ATMP Development! We are thrilled to share that four pioneering consortia - NXTGEN Hightech, RegMed XB, Biotech Booster, and Oncode Accelerator - have come together at the Innovation Center for Advanced Therapies (ICAT)) in Utrecht to drive the development of advanced therapies (ATMPs). During this event, we celebrated our progress, outlined future plans, and identified key areas for collaboration. We’re also issuing a call for new partners to join us on this innovative journey. To read the full press release > https://lnkd.in/g7fauGSV #ATMP #Innovation #Collaboration #Healthcare #GrowthFund #AdvancedTherapies Edwin Roovers Sabine Middendorp Ingrid Relou
Joining forces to accelerate development of ATMPs
nxtgenhightech.nl
-
Join our upcoming webinar: MDR Compliance – Key Lessons from a Medical Product Launch! Are you navigating the complex world of medical regulations? Don't miss this insightful session, in collaboration with High Tech NL, on October 17, 2024, from 16:00 to 17:00 CET, where we’ll explore the critical journey of bringing a medical product to market. 🎤 Featured speaker: Henk Stapert, CTO of smartQare, will share his experiences with the development and market introduction of viQtor, an innovative remote patient monitoring solution that received MDR approval in late 2022. What you'll learn: 👉 The importance of early regulatory involvement 👉 Key milestones for a successful product launch This webinar is perfect for professionals in Bio- and Medical Technology or Life Sciences who want to accelerate their path to market success. Spaces are limited – register now to secure your spot! To register > https://lnkd.in/epHtAVVi Have questions? Email them in advance to [email protected], and we’ll answer them during the session! #MDR #MedTech #Webinar #Compliance #Innovation #MedicalDevices #Biotech #Regulations #ProductLaunch High Tech NL NXTGEN Hightech Edwin Roovers Sabine Middendorp Ingrid Relou
MDR Compliance – Key Lessons from a Medical Product Launch
hightechnl.webinargeek.com
-
Worldwide interest in innovative and sustainable kidney replacement therapy! Excited to share that on Monday, 2nd September, Karin Gerritsen delivered the invited Opening Plenary Lecture at the Annual Congress of the Australian and New Zealand Society of Nephrology (ANZSN) 2024 in Adelaide, Australia. Her talk focused on "Innovations in Kidney Replacement Technology and Sustainability", highlighting groundbreaking advancements that NXTGEN Biomed04 (Artificial Organs) is working on to create more sustainable solutions for kidney replacement therapy. We’re proud to be at the forefront of this vital work and to see global attention on the future of nephrology. More information about the congress > https://anzsnasm.com/ #Innovation #Sustainability #Nephrology #KidneyReplacement #ANZSN2024 NXTGEN Hightech
-
Biomed | NXTGEN Hightech heeft dit gerepost
The AOT PhD students, Roberto Nese and Marc Torrents (both working at NXTGEN HighTech, Biomed 4 project) presenting their posters at the annual meeting of the European Society for artificial Organs (ESAO 2024, 8-11 September 2024, Aachen Germany)
-
The Dutch National Growth Fund (Nationaal Groeifonds) project, NXTGEN Hightech Biomed, working on artificial organs, has published the article: “Transportable, portable, wearable, and (partially) implantable #hemodialysis systems: Comparison of technologies and readiness levels.” The article explains how the development of modular technologies can help realize the roadmap toward better care and greater mobility for patients with #kidney failure. A PDF-version is downloadable here for free: https://lnkd.in/e4CU3xQf Fokko Pieter Wieringa Heleen Rienstra #artificialorgans #lifescience, #innovation, #healthcare
Transportable, portable, wearable and (partially) implantable hemodialysis systems: comparison of technologies and readiness levels
academic.oup.com
-
Yesterday, Biomed | NXTGEN Hightech and High Tech NL hosted the first in a series of upcoming webinars. This session focused on "Navigating the Regulatory Landscape for Innovative Biomedical Applications" in collaboration with Sue Spencer and Robert Paassen from Qserve Group. For those who couldn’t attend, we're pleased to share the replay with you here: https://lnkd.in/evJqb_-r Stay tuned, and check our agenda for more insightful webinars in the near future! NXTGEN Hightech #lifescience #biomedical #innovation, #healthcare #biotechnology #engineering #biosensing #organonchip #labonchip #cellproduction #artificialorgans
Navigating the Regulatory Landscape for Innovative Biomedical Applications - WebinarGeek
hightechnl.webinargeek.com
-
Last Call: Join Our Webinar Tomorrow! This is your last chance to attend our upcoming webinar: "Navigating the Regulatory Landscape for Innovative Biomedical Applications." 🗓 Date: 03.09.2024 🕒 Time: 16:00 CET Attendees will gain valuable insights into: - The importance of early regulatory involvement - Essential milestones necessary for preparing the launch of your biomedical innovations https://lnkd.in/eFcz7cqe
Navigating the Regulatory Landscape for Innovative Biomedical Applications
hightechnl.webinargeek.com
-
Biomed Domain Meeting Recap - August 26, 2024 > Last week, the Biomed domain had another engaging meeting where we delved into the topic of control points. It was a productive session that got our partners actively involved. While there were some slightly diverging views, it was incredibly valuable in raising awareness. The discussion was highly interactive, positive, and insightful—fantastic teamwork as we work toward building a strong #OoC (Organ-on-a-Chip) market strategy! We left with fresh perspectives and new insights to drive us forward. Looking forward to continuing the momentum! A big thank you to Jos Oudenhoven and imec for organizing and hosting the session. Jos put a lot of time and effort into making this happen. #lifescience #biomedical #innovation #healthcare #biotechnology, #engineering #organonchip #Teamwork #Innovation
-
Mooie ontwikkelingen en goed initiatief van BioMed Elements !
De Europese Unie 🇪🇺. Lijkt misschien ver weg, maar kan veel betekenen voor bedrijven in Gelderland. Bijvoorbeeld voor BioMed Elements uit Nijmegen. BioMed Elements ontwikkelt een gel voor mensen met een chronische ontsteking in de neusholte. Ze werken samen met zowel Nederlandse 🇳🇱 als Duitse 🇩🇪 partners. “Duitse kno-artsen die ik spreek werken misschien maar op een uur rijden van ons, maar ze zijn anders opgeleid. Ze gebruiken andere technieken en soms andere hulpmiddelen en medicijnen. Om te weten of ons product helpt, moeten we dat dus niet alleen onderzoeken bij Nederlandse chirurgen, maar ook in het buitenland”, vertelt Tonny Voermans. Om kennis en kunde met onze buren te delen, en andersom, zijn er subsidies beschikbaar. Maar naast subsidies, brengt het netwerk wat je opbouwt nog veel meer. 🤝 Meer lezen? In dit artikel lees je meer over deze waardevolle grensoverschrijdende samenwerking: https://bit.ly/3YOlxAK #biomed #inspirerendeondernemers #provinciegelderland Biomed | NXTGEN Hightech